Special Report: Wellnex Life has achieved a key milestone with a new market authorisation by Australia’s Therapeutic Goods Administration for a liquid paracetamol plus caffeine soft gel.

Wellnex Life (ASX:WNX) managing director Zack Bozinovski admits that local investors don’t fully understand the power and ...

The company now has four market approvals for its liquid soft gel portfolio, with others including: Liquid Paracetamol Liquid Paracetamol plus Ibuprofen; and Liquid Mini-Ibuprofen Wellnex’s four ...

Special Report: Directors are showing their support in the growth prospects of Wellnex Life as it prepares to list on the ...

The directors of diverse consumer healthcare business Wellnex Life (ASX: WNX) have committed to subscribe for a minimum of $1 ...

Microba Life Sciences (ASX:MAP), which has technology for measuring the gut microbiome, has a strategic partnership deal with ...

Special Report: Wellnex Life has announced it has now received conditional binding commitments of $14.3 million at 65 cents ...

Wellnex Life has taken a significant step towards its proposed dual listing on the AIM market of the London Stock Exchange ...

Nurofen or nurofen plus contains ibuprofen said to relieve general ... Mouth ulcer: Preparations such as anbesol liquid or rinstead adult gel containing local anaesthetics numbs the surface ...

The company had previously been granted MAs for liquid paracetamol, liquid paracetamol plus ibuprofen and liquid mini-ibuprofen ... “The approval of liquid paracetamol plus caffeine soft gel market ...